not quite significantp = 0.09
Both trials were terminated early and were underpowered, but if combined, overall mortality in CCP‐treated participants was 14 of 94, compared to 23 of 93 in controls, a 40% reduction, which, while not quite significant at the 0.05 level ( p = 0.09), cannot be dismissed in the face of an epidemic.